vs
Ascendis Pharma A/S（ASND）与CSW INDUSTRIALS, INC.（CSW）财务数据对比。点击上方公司名可切换其他公司
Ascendis Pharma A/S的季度营收约是CSW INDUSTRIALS, INC.的1.1倍（$267.3M vs $233.0M），Ascendis Pharma A/S同比增速更快（42.3% vs 20.3%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 5.1%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
ASND vs CSW — 直观对比
营收规模更大
ASND
是对方的1.1倍
$233.0M
营收增速更快
ASND
高出22.0%
20.3%
两年增速更快
ASND
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $233.0M |
| 净利润 | — | $10.3M |
| 毛利率 | 90.5% | 39.7% |
| 营业利润率 | — | 7.4% |
| 净利率 | — | 4.4% |
| 营收同比 | 42.3% | 20.3% |
| 净利润同比 | — | -61.9% |
| 每股收益（稀释后） | — | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDCSW
| Q4 25 | $267.3M | $233.0M | ||
| Q3 25 | $230.7M | $277.0M | ||
| Q2 25 | $170.7M | $263.6M | ||
| Q1 25 | $109.0M | $230.5M | ||
| Q4 24 | $187.8M | $193.6M | ||
| Q3 24 | $62.5M | $227.9M | ||
| Q2 24 | $38.9M | $226.2M | ||
| Q1 24 | $103.6M | $210.9M |
净利润ASNDCSW
| Q4 25 | — | $10.3M | ||
| Q3 25 | $-65.9M | $40.7M | ||
| Q2 25 | $-42.0M | $40.9M | ||
| Q1 25 | $-102.2M | $35.1M | ||
| Q4 24 | — | $26.9M | ||
| Q3 24 | $-107.1M | $36.1M | ||
| Q2 24 | $-118.1M | $38.6M | ||
| Q1 24 | $-141.5M | $31.8M |
毛利率ASNDCSW
| Q4 25 | 90.5% | 39.7% | ||
| Q3 25 | 89.5% | 43.0% | ||
| Q2 25 | 80.1% | 43.8% | ||
| Q1 25 | 82.6% | 44.2% | ||
| Q4 24 | 91.9% | 41.4% | ||
| Q3 24 | 80.6% | 45.6% | ||
| Q2 24 | 68.2% | 47.5% | ||
| Q1 24 | 92.1% | 44.4% |
营业利润率ASNDCSW
| Q4 25 | — | 7.4% | ||
| Q3 25 | 5.1% | 20.5% | ||
| Q2 25 | -33.5% | 20.8% | ||
| Q1 25 | -103.2% | 19.5% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | -167.3% | 22.6% | ||
| Q2 24 | -370.2% | 24.3% | ||
| Q1 24 | -51.2% | 21.0% |
净利率ASNDCSW
| Q4 25 | — | 4.4% | ||
| Q3 25 | -28.5% | 14.7% | ||
| Q2 25 | -24.6% | 15.5% | ||
| Q1 25 | -93.7% | 15.2% | ||
| Q4 24 | — | 13.9% | ||
| Q3 24 | -171.5% | 15.8% | ||
| Q2 24 | -303.9% | 17.1% | ||
| Q1 24 | -136.6% | 15.1% |
每股收益（稀释后）ASNDCSW
| Q4 25 | — | $0.62 | ||
| Q3 25 | — | $2.41 | ||
| Q2 25 | — | $2.43 | ||
| Q1 25 | — | $2.05 | ||
| Q4 24 | — | $1.60 | ||
| Q3 24 | — | $2.26 | ||
| Q2 24 | — | $2.47 | ||
| Q1 24 | — | $2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $40.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $1.1B |
| 总资产 | $1.4B | $2.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDCSW
| Q4 25 | $665.3M | $40.2M | ||
| Q3 25 | $582.2M | $31.5M | ||
| Q2 25 | $533.6M | $38.0M | ||
| Q1 25 | $559.4M | $225.8M | ||
| Q4 24 | $604.3M | $213.8M | ||
| Q3 24 | $675.6M | $273.2M | ||
| Q2 24 | $279.4M | $18.9M | ||
| Q1 24 | $345.9M | $22.2M |
总债务ASNDCSW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $800.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $166.0M |
股东权益ASNDCSW
| Q4 25 | $-175.8M | $1.1B | ||
| Q3 25 | $-188.0M | $1.1B | ||
| Q2 25 | $-202.6M | $1.1B | ||
| Q1 25 | $-205.0M | $1.1B | ||
| Q4 24 | $-114.2M | $1.0B | ||
| Q3 24 | $-105.1M | $1.0B | ||
| Q2 24 | $-346.8M | $650.2M | ||
| Q1 24 | $-257.2M | $615.7M |
总资产ASNDCSW
| Q4 25 | $1.4B | $2.3B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.3B | $1.4B | ||
| Q3 24 | $1.2B | $1.4B | ||
| Q2 24 | $819.0M | $1.1B | ||
| Q1 24 | $866.7M | $1.0B |
负债/权益比ASNDCSW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $28.9M |
| 自由现金流经营现金流 - 资本支出 | — | $22.7M |
| 自由现金流率自由现金流/营收 | — | 9.8% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 2.81× |
| 过去12个月自由现金流最近4个季度 | — | $162.0M |
8季度趋势，按日历期对齐
经营现金流ASNDCSW
| Q4 25 | $58.2M | $28.9M | ||
| Q3 25 | — | $61.8M | ||
| Q2 25 | — | $60.6M | ||
| Q1 25 | $-15.5M | $27.3M | ||
| Q4 24 | $-330.7M | $11.6M | ||
| Q3 24 | — | $66.8M | ||
| Q2 24 | — | $62.7M | ||
| Q1 24 | $-109.7M | $22.4M |
自由现金流ASNDCSW
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $58.7M | ||
| Q2 25 | — | $57.7M | ||
| Q1 25 | — | $22.8M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $61.3M | ||
| Q2 24 | — | $59.6M | ||
| Q1 24 | — | $17.5M |
自由现金流率ASNDCSW
| Q4 25 | — | 9.8% | ||
| Q3 25 | — | 21.2% | ||
| Q2 25 | — | 21.9% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 26.9% | ||
| Q2 24 | — | 26.3% | ||
| Q1 24 | — | 8.3% |
资本支出强度ASNDCSW
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 2.3% |
现金转化率ASNDCSW
| Q4 25 | — | 2.81× | ||
| Q3 25 | — | 1.52× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 1.85× | ||
| Q2 24 | — | 1.62× | ||
| Q1 24 | — | 0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
